BCG
TRDA icon

BayBridge Capital Group’s Entrada Therapeutics TRDA Stock Holding History

BayBridge Capital Group’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,563
Closed -$494K – 115
2024
Q4 		$494K Sell
28,563
-476
-2% -$8.23K 0.36% 66
2024
Q3 		$464K Buy
+29,039
New +$464K 0.33% 73